Loading
Life sciences · Journal article
International Journal of Molecular Sciences · October 8, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Transient Receptor Potential Ankyrin 1 (TRPA1) is a membrane cation channel activated by oxidative stress products that are chronically elevated in class III obesity. Although tissue-level TRPA1 biology is increasingly well described, the biological meaning of circulating immunoreactive TRPA1 remains poorly established. This single-centre, prospective, controlled observational study compared preoperative serum TRPA1 between adults with class III obesity scheduled for laparoscopic sleeve gastrectomy and contemporaneous controls, and explored metabolic and inflammatory correlates of the circulating signal. Serum TRPA1 was quantified by enzyme-linked immunosorbent assay (ELISA) in 42 consecutive surgical candidates and 36 controls. The primary analysis used continuous (log-transformed) TRPA1 with age- and sex-adjusted logistic regression; ROC-derived dichotomisation was retained only as an exploratory analysis. Serum TRPA1 did not differ between groups (median 309.8 vs. 340.5 pg/mL; Mann–Whitney U, p = 0.323; Hodges–Lehmann median difference [obesity − control] −30.8 pg/mL, bootstrap 95% CI −227.43 to 43.02). After adjustment for age and sex, continuous log-TRPA1 was not independently associated with obesity status (OR per log-unit 0.88, 95% CI 0.46–1.69; p = 0.699), and discrimination was poor (AUC 0.435; 95% CI 0.305–0.562). Established inflammatory and metabolic markers differed between groups, but serum TRPA1 did not track them. In this cohort, preoperative serum TRPA1 did not distinguish class III obesity from controls. The negative circulating finding should be interpreted as lack of evidence for a large between-group difference in ELISA-measured serum TRPA1—and as a potential translational disconnect from tissue TRPA1 biology—rather than as the definitive exclusion of any tissue-level role for the channel.